Neurofibromatosis Month – May. 1, 2027

Neurofibromatosis Month
Submit your updates or photos
Categories:
Tags:
AmericanDiseasesHealth
Where:
United States
Date change rule:
Every May
Holiday emoji:
🎗️

Neurofibromatosis Month is observed throughout May each year, dedicated to raising awareness and improving the visibility of this complex genetic disorder. This month highlights the challenges faced by individuals with NF, where tumors can grow in the nervous system. Learn about the symptoms, support research, and advocate for better treatments.

Want to sponsor Neurofibromatosis Month? Learn how

Expected Neurofibromatosis Month Deals

During Neurofibromatosis Month, the focus shifts from commercial deals to crucial fundraising and awareness initiatives. Organizations like the Children’s Tumor Foundation and NF Network spearhead campaigns, often partnering with corporate sponsors for donation matching programs. Look for special events, virtual walks, and educational webinars hosted by these groups. Pharmaceutical companies such as AstraZeneca and SpringWorks Therapeutics, who develop treatments for NF, may highlight their patient support programs and research efforts. Many individuals participate in peer-to-peer fundraising, encouraging friends and family to donate. We will update this page with specific campaign details as May approaches, directing readers to official channels for participation and support.

Platform Guide for Neurofibromatosis Month

Instagram

Tag @nationaltoday_ and use #NFMonth or #EndNF. Share infographics, patient stories, or photos from awareness events to spread visual information.

X/Twitter

Mention @NatlToday and use #NeurofibromatosisMonth. Engage in discussions, share research updates, and retweet advocacy messages from leading organizations.

Facebook

Mention National Today (facebook.com/nationaltoday) and use #NFawareness. Join community groups, share fundraising links, and promote local support events.

Social Media Tips for Neurofibromatosis Month

Individuals

Wear blue or green to show your support, share personal stories (if comfortable), and educate your social circle about the impact of neurofibromatosis.

Creators

Produce short videos explaining NF types, interview an advocate or researcher, or create a 'day in the life' video to highlight living with NF.

Brands

Launch a donation-matching campaign, sponsor a virtual event, or dedicate a portion of May's sales to an NF research foundation, promoting your involvement on social media.

Organizations & Brands for Neurofibromatosis Month

  1. Children's Tumor Foundation

    Founded in 1978, the Children's Tumor Foundation is a global leader in NF research and patient support. It funds groundbreaking studies, provides resources for families, and advocates for improved care and treatments for all forms of neurofibromatosis.

  2. NF Network

    Established in 1986, the NF Network is dedicated to advocating for federal funding for NF research and providing patient support services. It connects individuals and families affected by NF with resources, education, and a strong community.

  3. AstraZeneca

    A global pharmaceutical company, AstraZeneca is involved in developing treatments for various conditions, including neurofibromatosis type 1 (NF1). Their drug Koselugo (selumetinib) is approved for treating plexiform neurofibromas in pediatric NF1 patients.

  4. SpringWorks Therapeutics

    A clinical-stage biopharmaceutical company, SpringWorks Therapeutics focuses on developing therapies for rare diseases and cancer. They developed Ojemda (mirdametinib), an oral MEK inhibitor approved for treating adults with NF1-associated plexiform neurofibromas.

  5. GeneDx

    GeneDx is a leading provider of genetic testing, offering comprehensive diagnostic services for rare diseases, including neurofibromatosis. Their testing helps patients and clinicians understand genetic causes and guide treatment decisions.

  6. National Organization for Rare Disorders (NORD)

    NORD is a patient advocacy organization dedicated to helping people with rare diseases. Founded in 1983, it provides programs for patient assistance, education, advocacy, and research, supporting conditions like neurofibromatosis.

  7. Rare Disease United Foundation

    This foundation works to unite the rare disease community through education, advocacy, and support. They strive to empower patients and families, fostering collaboration among various rare disease groups, including those focused on NF.

Neurofibromatosis Month Hero

Friedrich Daniel von Recklinghausen

Friedrich Daniel von Recklinghausen (1833–1910) was a German pathologist who first described the condition now known as Neurofibromatosis Type 1 (NF1). In 1882, he published a detailed account of the clinical and pathological features of the disorder, distinguishing it from other conditions. His work laid the foundation for understanding NF as a distinct genetic disease, significantly advancing medical knowledge and paving the way for future research and patient care.

History of Neurofibromatosis Month

Neurofibromatosis Month is observed throughout the country in the month of May. It is an important way of improving the visibility of this disease among doctors and the general population to allow for early detection. The earlier that the disease is detected, the easier it is for individuals to manage their symptoms.

Neurofibromatosis is a group of three conditions. In all these conditions tumors grow on nerves throughout the body. The three types of neurofibromatosis are N.F.1, N.F.2, and N.F.3. All these types are caused by mutations in specific genes called ‘oncogenes.’ This is a gene that has the potential to cause cancer. Despite this, the tumors that are caused by neurofibromatosis are rarely cancerous. Different mutations in the oncogenes cause the different types of the disease.

There is no known cure for any of the different types of neurofibromatosis. The disease is likely genetic, but there is insufficient research done into the causes. More often than not, neurofibromatosis occurs spontaneously during early development. This makes it an important cause of concern for children. The symptoms of the disease typically worsen with time and the tumors may become cancerous. At this point, the tumors are removed surgically. Raising awareness and educating people about neurofibromatosis is of great importance. It may help people with the disease with early diagnosis and treatment to manage symptoms. The month is also an opportunity for people living with the disease to share their stories that give hope to people who have been newly diagnosed with the disease.

Neurofibromatosis Month timeline

1st Century A.D.
Descriptions Record the Disease

Descriptions of symptoms that match neurofibromatosis are recorded in medical practice.

1882
The Disease is Formally Described

German pathologist Friedrich Daniel von Recklinghausen formally describes neurofibromatosis.

1900s
Research Into Neurofibromatosis Increases

From 1909 onwards, the research into the conditions increases.

1987
Different Types Identified

A panel of the National Institutes of Health identifies the different types of neurofibromatosis.

How Businesses Can Celebrate Neurofibromatosis Month

Local businesses can honor Neurofibromatosis Month by hosting fundraising events or dedicating a portion of May’s proceeds to an NF research foundation. Restaurants might offer a special ‘awareness dish,’ with proceeds going to a local NF support group. Retailers could feature informational displays about NF and provide opportunities for customers to round up their purchases for donations. Partnering with local advocacy groups for educational seminars or sponsored walks can also raise visibility and encourage community involvement.

Neurofibromatosis Month FAQs

When is Neurofibromatosis Month?

In 2027, Neurofibromatosis Month will again be observed throughout May. It’s a key period for advocacy, research, and community engagement around this genetic disorder.

How many people are affected by neurofibromatosis?

Globally, millions of people live with neurofibromatosis, with NF1 being the most prevalent form. Continued awareness efforts in 2027 aim to reach more individuals and ensure accurate diagnosis and support for all affected.

What are the types of neurofibromatosis?

While all types of NF involve non-cancerous tumor growth, NF1 is characterized by skin and bone changes, NF2 by tumors on the auditory nerves, and Schwannomatosis by tumors on peripheral nerves. Understanding these differences is crucial for diagnosis and tailored treatment plans.

Is neurofibromatosis hereditary?

For families affected by NF, genetic counseling is often recommended to understand the inheritance patterns and risks. The hereditary nature means NF can run in families, though new mutations are also common.

How to Observe Neurofibromatosis Month

  1. Educate people about N.F.

    Many people don’t know about N.F. and make unfounded assumptions. Educate your friends and family about this disease during this month.

  2. Contribute to fundraising campaigns

    There is no known cure for this disease. Support people with N.F. by contributing to researchers looking to improve their quality of life and find a cure. This is the best form of help.

  3. Share patients’ stories

    Diseases like N.F. can be very isolating. Share stories of people with N.F. and help others with the disease feel less alone. It also motivates newer patients.

5 Facts About Neurofibromatosis That You Probably Didn’t Know

  1. N.F.1 doesn’t need prolonged treatment

    People with N.F.1 need to be monitored periodically by a specialist but typically don’t need long-term treatment.

  2. Vision loss is common with N.F.2

    Children and teenagers with N.F.2 can develop cataracts and frequently the disease is diagnosed as a result of vision loss.

  3. Many people have the disease

    About two million around the world suffer from one of the three different types of the disease.

  4. The tumors can affect the entire body

    The tumors associated with N.F. primarily grow on the nerves, but they can spread to the brain, cardiovascular system, bones, and skin.

  5. Clinical trials are ongoing

    Current treatments are limited, but clinical trials are in progress to improve the quality of life for people with N.F.

Why Neurofibromatosis Month is Important

  1. We want to spread the word

    We think that more people should be aware of N.F., so they can get genetic counseling. We also think that people should be informed about the available treatments if they suspect they have N.F.

  2. We want to educate people

    People who have visible symptoms of N.F. are often reduced to their disease. We want to educate people so that they learn how to accommodate and treat people with the disease.

  3. We want to support patients

    We think that patients with N.F. have difficult lives, and we want to help them. We want to support them in their treatments and help fund research that improves their quality of life.

Neurofibromatosis Month dates

Year Date Day
2027 May 1 Saturday
2028 May 1 Monday
2029 May 1 Tuesday
2030 May 1 Wednesday
2031 May 1 Thursday